Following intramuscular injection, Risvan forms a depot that provides sustained plasma levels over the monthly interval. The Food and Drug Administration (FDA) has approved Risvan ® (risperidone for ...
A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.
Syringe and Vials Patients treated with the investigational subcutaneous risperidone injection experienced a statistically significant delay in the time to relapse. The Food and Drug Administration ...
May 27, 2009 — The US Food and Drug Administration (FDA) has approved risperidone long-acting injection for use alone or with lithium or valproate in the treatment of bipolar I disorder; and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results